Trials / Conditions / Mixed Phenotype Acute Leukemia (MPAL)
Mixed Phenotype Acute Leukemia (MPAL)
3 registered clinical trials studyying Mixed Phenotype Acute Leukemia (MPAL) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Subcutaneous Blinatumomab for Treatment of Adult Patients With CD19-Positive Mixed Phenotype Acute Leukemia (M NCT07222579 | West Virginia University | Phase 2 |
| Completed | Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL NCT04827745 | University of Maryland, Baltimore | Phase 2 |
| Completed | Selinexor With Fludarabine and Cytarabine for Treatment of Refractory or Relapsed Leukemia or Myelodysplastic NCT02212561 | St. Jude Children's Research Hospital | Phase 1 |